Implementing the Spotlight AQ Platform in Adolescent/ Young Adult (16-25 Years Old) Type 1 Diabetics (T1D)

Launched by CHILDREN'S MERCY HOSPITAL KANSAS CITY · Apr 25, 2024

Keywords

ClinConnect Summary

This clinical trial is exploring a new tool called the Spotlight AQ survey to see if it can help improve diabetes management for young people aged 16 to 25 who have Type 1 Diabetes (T1D). The main goals are to find out if using the Spotlight AQ survey before clinic visits can lower blood sugar levels (measured by A1c) and to see how much patients and doctors like using this tool compared to the usual pre-visit assessments.

To participate, individuals must be between 16 and 25 years old, have been diagnosed with T1D for at least six months, and be using a Continuous Glucose Monitor (CGM). They should also be able to communicate in English or Spanish. Participants will complete the Spotlight AQ survey before two routine clinic visits and may share their thoughts about the survey through interviews. The trial is currently looking for eligible participants, so if you or someone you know fits the criteria, this could be a great opportunity to contribute to diabetes care research.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 16-25 years old
• • Patients diagnosed with T1D for at least 6 months
• • On any diabetes treatment
• • Using a Continuous Glucose Monitor (CGM)
• • Willing/ able to use Spotlight AQ tool
• • Able to give verbal assent
• • Patients \& parents/caregiver speak English/ Spanish fluently
• • Patients in the Children's Mercy Kansas City Hospital or Boston Children's Hospital network
• Exclusion Criteria:
• • \<16 years old or \>25 years old
• • Mental illness that could seriously reduce their ability to participate in the study
• • Lack of capacity
• • In another T1D intervention study